Progyny Company Insiders

PGNY Stock  USD 16.13  0.22  1.35%   
Progyny's insiders are aggressively selling. The analysis of insiders' sentiment of trading Progyny stock suggests that vertually all insiders are panicking at this time. Progyny employs about 563 people. The company is managed by 13 executives with a total tenure of roughly 1314 years, averaging almost 101.0 years of service per executive, having 43.31 employees per reported executive.

Progyny's Insider Buying Vs Selling

0

 
Selling
 
Buying

Latest Trades

2024-07-16Michael E SturmerDisposed 9030 @ 30View
2024-06-28Cheryl ScottDisposed 1462 @ 28.39View
2024-05-01Michael E SturmerDisposed 4515 @ 31.95View
2024-04-01Michael E SturmerDisposed 6395 @ 37.6View
2024-03-27David J SchlangerDisposed 71272 @ 37.8View
2024-03-25David J SchlangerDisposed 2597 @ 37.65View
2024-03-21David J SchlangerDisposed 5826 @ 37.74View
2024-02-06Michael E SturmerDisposed 2260 @ 40View
2024-02-05David J SchlangerDisposed 20000 @ 38.5View
2024-01-08David J SchlangerDisposed 66002 @ 37.88View
2024-01-02Michael E SturmerDisposed 6395 @ 36.81View
2023-12-26David J SchlangerDisposed 80000 @ 37.93View
2023-12-21David J SchlangerDisposed 80000 @ 37.65View
2023-12-14David J SchlangerDisposed 1063 @ 37.53View
2023-12-11Kevin K GordonDisposed 2500 @ 35.93View
2023-12-01Mark S LivingstonDisposed 25087 @ 34.62View
Monitoring Progyny's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Progyny. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For more information on how to buy Progyny Stock please use our How to Invest in Progyny guide.

Progyny's Workforce Through the Years

Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Progyny's future performance. Based on our forecasts, it is anticipated that Progyny will maintain a workforce of slightly above 560 employees by November 2024.
 
Covid

Progyny Management Team Effectiveness

The company has return on total asset (ROA) of 0.0645 % which means that it generated a profit of $0.0645 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1356 %, meaning that it created $0.1356 on every $100 dollars invested by stockholders. Progyny's management efficiency ratios could be used to measure how well Progyny manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to rise to 0.09 in 2024. Return On Capital Employed is likely to rise to 0.11 in 2024. At this time, Progyny's Total Assets are fairly stable compared to the past year. Net Tangible Assets is likely to rise to about 440.7 M in 2024, whereas Non Current Assets Total are likely to drop slightly above 69.4 M in 2024.
Common Stock Shares Outstanding is likely to rise to about 101.6 M in 2024, whereas Net Income Applicable To Common Shares is likely to drop slightly above 22.1 M in 2024.

Progyny Workforce Comparison

Progyny is rated below average in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 65,021. Progyny maintains roughly 563 in number of employees contributing less than 1% to equities under Health Care industry.

Progyny Profit Margins

The company has Profit Margin (PM) of 0.06 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.07 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.07.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.160.2194
Way Down
Slightly volatile

Progyny Insider Trading History

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Progyny insiders, such as employees or executives, is commonly permitted as long as it does not rely on Progyny's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Progyny insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Yuan Drop
 
Covid
Buy/Sell Ratio# Purchases Trades# Sales TradesTotal Shares PurchasedTotal Shares Sold
2024-06-01
1.0588
18
17
 262,930 
 81,031 
2024-03-01
0.34
17
50
 1,246,000 
 666,759 
2023-12-01
0.2667
8
30
 450,500 
 864,843 
2023-09-01
0.2593
7
27
 205,001 
 3,348,332 
2023-06-01
0.4063
39
96
 979,528 
 3,069,741 
2023-03-01
0.2184
19
87
 626,884 
 1,687,574 
2022-12-01
0.4113
51
124
 2,165,398 
 1,760,072 
2022-09-01
0.119
15
126
 380,334 
 1,158,326 
2022-06-01
0.25
13
52
 664,224 
 485,537 
2022-03-01
0.1532
17
111
 2,262,703 
 2,267,450 
2021-12-01
0.25
36
144
 1,260,724 
 2,945,419 
2021-09-01
0.18
18
100
 937,168 
 2,316,121 
2021-06-01
0.2538
33
130
 2,911,489 
 9,937,459 
2021-03-01
0.1974
30
152
 2,578,688 
 8,964,224 
2020-12-01
0.1899
45
237
 3,468,004 
 14,301,056 
2020-09-01
0.1169
29
248
 3,680,215 
 12,799,690 
2020-06-01
0.1127
16
142
 364,484 
 5,655,782 
2020-03-01
1.3333
8
6
 1,561,327 
 4,266,395 
2019-12-01
0.4783
22
46
 66,486,590 
 97,639,666 

Progyny Notable Stakeholders

A Progyny stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Progyny often face trade-offs trying to please all of them. Progyny's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Progyny's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
David SchlangerExecutive ChairmanProfile
Julie StadlbauerEx PartnershipsProfile
Katie HigginsChief OfficerProfile
Risa FisherChief OfficerProfile
Cassandra PrattSenior PeopleProfile
Peter AnevskiCEO DirectorProfile
Steven LeistChief OfficerProfile
Michael SturmerPresidentProfile
Allison SwartzGeneral SecretaryProfile
James HartVice RelationsProfile
Arielle BogoradSenior StrategyProfile
Mark LivingstonChief OfficerProfile
Janet MDMember OfficerProfile

About Progyny Management Performance

The success or failure of an entity such as Progyny often depends on how effective the management is. Progyny management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Progyny management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Progyny management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets 0.08  0.09 
Return On Capital Employed 0.11  0.11 
Return On Assets 0.08  0.09 
Return On Equity 0.11  0.12 
Please note, the imprecision that can be found in Progyny's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Progyny. Check Progyny's Beneish M Score to see the likelihood of Progyny's management manipulating its earnings.

Progyny Workforce Analysis

Traditionally, organizations such as Progyny use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Progyny within its industry.

Progyny Manpower Efficiency

Return on Progyny Manpower

Revenue Per Employee1.9M
Revenue Per Executive83.7M
Net Income Per Employee110.2K
Net Income Per Executive4.8M
Working Capital Per Employee807.2K
Working Capital Per Executive35M

Additional Tools for Progyny Stock Analysis

When running Progyny's price analysis, check to measure Progyny's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Progyny is operating at the current time. Most of Progyny's value examination focuses on studying past and present price action to predict the probability of Progyny's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Progyny's price. Additionally, you may evaluate how the addition of Progyny to your portfolios can decrease your overall portfolio volatility.